-
Signature
-
/s/ Neha Krishnamohan, Attorney-in-Fact
-
Issuer symbol
-
ARTV
-
Transactions as of
-
15 Nov 2025
-
Net transactions value
-
-$42,150
-
Form type
-
4
-
Filing time
-
17 Nov 2025, 20:37:55 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Aslan Fred |
President and CEO, Director |
C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO |
/s/ Neha Krishnamohan, Attorney-in-Fact |
17 Nov 2025 |
0001909362 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ARTV |
Common Stock |
Tax liability |
$20,628 |
-6,347 |
-1.8% |
$3.25 |
350,374 |
15 Nov 2025 |
Direct |
F1 |
| transaction |
ARTV |
Common Stock |
Sale |
$21,522 |
-6,375 |
-1.8% |
$3.38 |
343,999 |
17 Nov 2025 |
Direct |
F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: